These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 18710399

  • 1. Disposition of eslicarbazepine acetate in the mouse after oral administration.
    Alves G, Figueiredo I, Castel-Branco M, Lourenço N, Falcão A, Caramona M, Soares-da-Silva P.
    Fundam Clin Pharmacol; 2008 Oct; 22(5):529-36. PubMed ID: 18710399
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection.
    Alves G, Figueiredo I, Castel-Branco M, Loureiro A, Falcão A, Caramona M.
    Anal Chim Acta; 2007 Jul 16; 596(1):132-40. PubMed ID: 17616250
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma.
    Alves G, Figueiredo I, Castel-Branco M, Loureiro A, Fortuna A, Falcão A, Caramona M.
    Biomed Chromatogr; 2007 Nov 16; 21(11):1127-34. PubMed ID: 17594694
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and drug interactions of eslicarbazepine acetate.
    Bialer M, Soares-da-Silva P.
    Epilepsia; 2012 Jun 16; 53(6):935-46. PubMed ID: 22612290
    [Abstract] [Full Text] [Related]

  • 9. A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain.
    Fortuna A, Alves G, Almeida A, Lopes B, Falcão A, Soares-da-Silva P.
    Biomed Chromatogr; 2012 Mar 16; 26(3):384-92. PubMed ID: 21780155
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
    Kim TH, Reid CA, Petrou S.
    Epilepsia; 2015 Jan 16; 56(1):e6-9. PubMed ID: 25489632
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
    Perucca E, Elger C, Halász P, Falcão A, Almeida L, Soares-da-Silva P.
    Epilepsy Res; 2011 Sep 16; 96(1-2):132-9. PubMed ID: 21680153
    [Abstract] [Full Text] [Related]

  • 13. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T, Rocha JF, Falcão A, Almeida L, Soares-da-Silva P.
    Epilepsia; 2013 Jan 16; 54(1):108-16. PubMed ID: 22812691
    [Abstract] [Full Text] [Related]

  • 14. Enantioselective assay for therapeutic drug monitoring of eslicarbazepine acetate: no interference with carbamazepine and its metabolites.
    Alves G, Fortuna A, Sousa J, Direito R, Almeida A, Rocha M, Falcão A, Soares-da-Silva P.
    Ther Drug Monit; 2010 Aug 16; 32(4):512-6. PubMed ID: 20592643
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma.
    Loureiro AI, Fernandes-Lopes C, Wright LC, Soares-da-Silva P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep 01; 879(25):2611-8. PubMed ID: 21816689
    [Abstract] [Full Text] [Related]

  • 16. Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma.
    Fortuna A, Sousa J, Alves G, Falcão A, Soares-da-Silva P.
    Anal Bioanal Chem; 2010 Jun 01; 397(4):1605-15. PubMed ID: 20401721
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans.
    Almeida L, Soares-da-Silva P.
    J Clin Pharmacol; 2004 Aug 01; 44(8):906-18. PubMed ID: 15286095
    [Abstract] [Full Text] [Related]

  • 20. Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
    Maia J, Almeida L, Falcão A, Soares E, Mota F, Potgieter MA, Potgieter JH, Soares-da-Silva P.
    Int J Clin Pharmacol Ther; 2008 Mar 01; 46(3):119-30. PubMed ID: 18397682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.